This article, originally published by our sister brand Nutritional Outlook, covered updates from the U.S. Food and Drug Administration and Federal Trade Commission on their jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.
The U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act. These companies included: Hippy Mood, Earthly Hemps, Shamrockshrooms.com, Mary Janes Bakery Co. LLC and Life Leaf Medical CBD Center. FDA independently issued a warning letter to GrowGod LL for the same violations.
According to a press release from FDA, the warning letters are part of the agencies’ ongoing efforts to take action against companies selling copycat foods with delta-8 THC. In July of 2023, the two agencies issued warning letters to six companies for the same violations. The first warning letters sent to delta-8 THC companies were sent to five companies in May of 2022 by FDA. Copycat foods containing delta-8 THC have packaging that may be confused for products sold by popular national brands. The six companies previously sent warning letters no longer sell these copycat food products, says FDA in a statement.
“Inadequate or confusing labeling can result in children or unsuspecting adults consuming products with strong resemblance to popular snacks and candies that contain delta-8 THC without realizing it,” said FDA Principal Deputy Commissioner Namandjé Bumpus, PhD, in a press release. “As accidental ingestion and/or overconsumption of delta-8 THC containing products could pose considerable health risks, the companies who sell these illegal products are demonstrating complete neglect for consumer safety. The FDA will continue to work to safeguard the health and safety of U.S. consumers by monitoring the marketplace and taking action when companies sell products that present a threat to public health.”
According to FDA, between January 1, 2021 and December 31, 2023, the agency received over 300 adverse event reports involving children and adults who had consumed delta-8 THC products. They explain that nearly half of these reports involved hospitalization or emergency department visits. Approximately two-thirds of these events followed ingestion of food products containing delta-8 THC, such as candy or brownies. The adverse events listed included: hallucinations, vomiting, tremor, anxiety, dizziness, confusion, and loss of consciousness.
Many of the offending products are difficult to distinguish from many popular snack brands. “Companies that market and sell edible THC products that are easily mistaken for snacks and candy are not only acting illegally, but they are also putting the health of young children at risk,” said Samuel Levine, director of the FTC’s Bureau of Consumer Protection, in a statement. “Those that prioritize profits in front of children's safety are at serious risk of legal action.”
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.